StockData
AbbVie Inc. logo

AbbVie Inc. (ABBV) stock

ABBVNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 10/3090% above fair value
$294.55−0.48 (-0.16%)

Close on Nov 16, 2026Market cap $520.50BP/E 83.2Yield 2.26%

AbbVie EV/EBITDA

EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.

AbbVie's EV/EBITDA was 34.8× on Nov 11, 2026, against 51.6× a year earlier. Over the last 5 years it ranged from 17.3× to 51.8×, with a median of 28.1×.

EV/EBITDA at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 202634.8×−17.0
2025Dec 31, 202551.8×+24.4
2024Dec 31, 202427.4×+6.0
2023Dec 29, 202321.4×+1.9
2022Dec 30, 202219.5×+0.9
2021Dec 31, 202118.6×−3.0
2020Dec 31, 202021.6×−2.6
2019Dec 31, 201924.2×+7.6
2018Dec 31, 201816.7×−1.6
2017Dec 29, 201718.2×+3.8
2016Dec 30, 201614.4×−9.4
2015Dec 31, 201523.8×+2.9
2014Dec 31, 201421.0×+5.9
2013Dec 31, 201315.1×–

More AbbVie figures

See a number that looks wrong?